Slide 1Identifying Meaningful Patient Subgroups via Clustering - Sensitivity Graphics Bob Obenchain Commercial Information Sciences Outcomes Research, US Medical Division…
Slide 1Bias Correction in Pharmaceutical Risk-Benefit Assessment Bob Obenchain, PhD, FASA Risk-Benefit Statistics LLC Yin = Dark = Evil = Risk Yang = Light = Good = Benefit…